K Daniel Spiegelman

Affiliations

  • Director at Myriad Genetics Inc (MYGN), 2021-06-17
  • Director at Spruce Biosciences Inc. (SPRB), 2021-05-22
  • Director at Jiya Acquisition Corp. (JYAC), 2020-11-19
  • Evp, Chief Financial Officer at Biomarin Pharmaceutical Inc (BMRN), 2019-06-07
  • Director at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • at Anthera Pharmaceuticals Inc (ANTH), 2014-06-16
  • Director at Affymax Inc (AFFY), 2012-06-18
  • Director at Omeros Corp (OMER), 2012-06-04
  • Director at Cyclacel Pharmaceuticals Inc. (CYCC), 2012-05-25
  • Officer at Cv Therapeutics Inc (CVTX), 2009-04-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ONTY $1.59 10,000 Director 40,644 2015-03-26 Filing
ONTY $1.63 10,000 Director 30,644 2015-03-25 Filing
ONTY $1.59 10,000 Director 40,644 2015-03-26 Filing
ONTY $1.63 10,000 Director 30,644 2015-03-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MYGN $30.52 3,139 Director 23,129 2021-06-17 Filing
MYGN $28.99 7,142 Director 13,420 2021-05-28 Filing
BMRN $89.00 13,473 Officer 47,510 2019-04-01 Filing
BMRN $90.00 100 Officer 60,983 2019-03-27 Filing
BMRN $99.01 472 Officer 51,070 2018-06-22 Filing